These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27334945)

  • 1. Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and Neuroinflammation.
    Catafau AM; Bullich S
    Curr Alzheimer Res; 2017; 14(2):169-177. PubMed ID: 27334945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers.
    Shah M; Catafau AM
    J Nucl Med; 2014 Jun; 55(6):871-4. PubMed ID: 24833492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography.
    Wang YT; Edison P
    Curr Neurol Neurosci Rep; 2019 Jun; 19(7):45. PubMed ID: 31172290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau-imaging in neurodegeneration.
    Bischof GN; Endepols H; van Eimeren T; Drzezga A
    Methods; 2017 Nov; 130():114-123. PubMed ID: 28790016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau imaging with PET: an overview of challenges, current progress, and future applications.
    Robertson JS; Rowe CC; Villemagne VL
    Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):405-413. PubMed ID: 28750496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule PET Tracers for Imaging Proteinopathies.
    Mathis CA; Lopresti BJ; Ikonomovic MD; Klunk WE
    Semin Nucl Med; 2017 Sep; 47(5):553-575. PubMed ID: 28826526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E; Nordberg A
    Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.
    Tronel C; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Dupont AC; Arlicot N
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation in Neurodegenerative Disorders-a Review.
    Schain M; Kreisl WC
    Curr Neurol Neurosci Rep; 2017 Mar; 17(3):25. PubMed ID: 28283959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.
    Jack CR; Wiste HJ; Weigand SD; Therneau TM; Knopman DS; Lowe V; Vemuri P; Mielke MM; Roberts RO; Machulda MM; Senjem ML; Gunter JL; Rocca WA; Petersen RC
    Lancet Neurol; 2017 Jun; 16(6):435-444. PubMed ID: 28456479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future Directions in Molecular Imaging of Neurodegenerative Disorders.
    Barthel H; Villemagne VL; Drzezga A
    J Nucl Med; 2022 Jun; 63(Suppl 1):68S-74S. PubMed ID: 35649650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein and tau: teammates in neurodegeneration?
    Moussaud S; Jones DR; Moussaud-Lamodière EL; Delenclos M; Ross OA; McLean PJ
    Mol Neurodegener; 2014 Oct; 9():43. PubMed ID: 25352339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
    Villemagne VL; Doré V; Burnham SC; Masters CL; Rowe CC
    Nat Rev Neurol; 2018 Apr; 14(4):225-236. PubMed ID: 29449700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET radiotracers for molecular imaging in dementia.
    Baskin A; Giannakopoulos P; Ratib O; Seimbille Y; Assal F; Perani D; Garibotto V
    Curr Radiopharm; 2013 Dec; 6(4):215-30. PubMed ID: 24283962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Neurodegenerative Disorders with Amyloid-β, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls.
    Burkett BJ; Johnson DR; Lowe VJ
    J Nucl Med; 2024 Jun; 65(6):829-837. PubMed ID: 38664015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cellular prion protein in interneuronal amyloid transmission.
    Del Río JA; Ferrer I; Gavín R
    Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Neuroinflammation in Neurodegenerative Disorders.
    Masdeu JC; Pascual B; Fujita M
    J Nucl Med; 2022 Jun; 63(Suppl 1):45S-52S. PubMed ID: 35649654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies.
    Perani D; Iaccarino L; Lammertsma AA; Windhorst AD; Edison P; Boellaard R; Hansson O; Nordberg A; Jacobs AH;
    Alzheimers Dement; 2019 Aug; 15(8):1081-1103. PubMed ID: 31230910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disclosing tau tangles using PET imaging: a pharmacological review of the radiotracers available in 2021.
    Van Wambeke É; Gérard T; Lhommel R; Hanseeuw B
    Acta Neurol Belg; 2022 Apr; 122(2):263-272. PubMed ID: 34713414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau imaging in neurodegenerative diseases.
    Dani M; Brooks DJ; Edison P
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1139-50. PubMed ID: 26572762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.